Imunon (IMNN) Long-Term Debt Issuances (2010 - 2020)

Imunon's (IMNN) quarterly Long-Term Debt Issuances came in at $692530.0 in Q2 2020, up 127.75% on a QoQ basis from -$2.5 million in Q4 2017.

Imunon (IMNN) Long-Term Debt Issuances (2010 - 2020) Analysis & Trends

Imunon (IMNN) has 9 years of Long-Term Debt Issuances data on file, last reported at $692530.0 in Q2 2020.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $692530.0 in Q2 2020, while the trailing twelve-month figure through Sep 2021 was $692530.0 (changed 0.0% YoY) and the FY2021 annual result came in at $5.8 million, up 334.54% from the prior year.
Long-Term Debt Issuances climbed to $692530.0 in Q2 2020, from -$2.5 million in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $1.5 million in Q2 2017 to a low of -$2.5 million in Q4 2017.
A 3-year average of $611547.1 and a median of $1.0 million in 2016 frame the typical range for Long-Term Debt Issuances.
The widest YoY moves for Long-Term Debt Issuances: up 48.63% in 2017, down 333.17% in 2017.
Tracing IMNN's Long-Term Debt Issuances over 3 years: stood at $1.1 million in 2016, then sank by 333.17% to -$2.5 million in 2017, then jumped by 127.75% to $692530.0 in 2020.
The last three Long-Term Debt Issuances figures came in at $692530.0 (Q2 2020), -$2.5 million (Q4 2017), and $1.5 million (Q2 2017), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Imunon	8.42 Mn	8.42 Mn	-	-

Download Data